摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1,1-二氧代四氢-3-噻吩基)肼 | 3448-12-2

中文名称
(1,1-二氧代四氢-3-噻吩基)肼
中文别名
3-环丁烯砜肼
英文名称
2-(1,1-dioxotetrahydrothiophen-3-yl)hydrazine
英文别名
3-Hydrazino-tetrahydro-thiophen-1.1-dioxid;3-Sulfolanylhydrazin;(tetrahydro-3-thienyl)hydrazine S,S-dioxide;(1,1-dioxidotetrahydro-3-thienyl)hydrazine;(1,1-dioxo-tetrahydro-thiophen-3-yl)-hydrazine;(sulfolane-3-yl) hydrazine;3-Hydrazinyltetrahydrothiophene 1,1-dioxide;(1,1-dioxothiolan-3-yl)hydrazine
(1,1-二氧代四氢-3-噻吩基)肼化学式
CAS
3448-12-2
化学式
C4H10N2O2S
mdl
MFCD00270815
分子量
150.202
InChiKey
DBBOTJJFLMUEIN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    427.6±34.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    80.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090

SDS

SDS:da1619deafb5551be404660c0c8b36c2
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1,1-二氧代四氢-3-噻吩基)肼3,6-endomethylene-1,2,3,6-tetrahydrophthalic anhydride 为溶剂, 以83%的产率得到endo-5-[N'-(1,1-dioxotetrahydrothiophen-3-yl)-hydrazinocarbonyl]bicyclo[2.2.1]hept-2-ene-endo-6-carboxylic acid
    参考文献:
    名称:
    内酸酐与肼和酰基肼的反应
    摘要:
    Reaction products of bicyclo[2.2.1]hept-2-ene-endo, endo-5,6-dicarboxylic (endic) acid with hydrazines and acylhydrazines were prepared. The features distinguishing of these reactions from those with amines were revealed. The compounds obtained were characterized by H-1, C-11 NMR, and IR spectra. The assignment of the signals in NMR spectra was done with the use of quantum-chemical calculations of chemical shifts performed by the density functional method. The structure of one among compounds synthesized, N-(m-hydroxybenzoylamino)-bicyclo[2.2.1] hept-2-ene-endo, endo-5,6-dicarboxamide, was proved by X-ray diffraction analysis.
    DOI:
    10.1023/b:rujo.0000045895.04509.2d
  • 作为产物:
    描述:
    tert-butyl N-[(1,1-dioxothiolan-3-yl)amino]carbamate 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 (1,1-二氧代四氢-3-噻吩基)肼
    参考文献:
    名称:
    Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators
    摘要:
    The present study describes the discovery and characterization of a series of 5-aryl-2H-tetrazol-3-ylacetamides as G protein-gated inwardly-rectifying potassium (GIRK) channels activators. Working from an initial hit discovered during a high-throughput screening campaign, we identified a tetrazole scaffold that shifts away from the previously reported urea-based scaffolds while remaining effective GIRK1/2 channel activators. In addition, we evaluated the compounds in Tier 1 DMPK assays and have identified a (3-methyl-1H-pyrazol-1-yl)tetrahydrothiophene-1,1-dioxide head group that imparts interesting and unexpected microsomal stability compared to previously-reported pyrazole head groups.
    DOI:
    10.1016/j.bmcl.2019.01.027
点击查看最新优质反应信息

文献信息

  • Antibacterial hydrazono cephalosporins
    申请人:Shionogi & Co., Ltd.
    公开号:US04101658A1
    公开(公告)日:1978-07-18
    Antibacterial cephalosporins of the following formula: ##STR1## WHEREIN A and B each is a hydrogen or an amino protecting group; X is a hydroxy or a carboxy protecting group; Y is a hydrogen, halogen, alkyl, alkoxy, or an alkylthio; R is a hydrogen or an alkyl; Z is a group of the formula ##STR2## (in which R.sup.1 and R.sup.2 are the same or different and are a hydrogen, optionally substituted hydrocarbon group, organic acyl, or a group of the formula ##STR3## respectively, in which M and M' are the same or different and are an oxygen or sulfur; R.sup.3 is a hydrocarbon group; R.sup.1 and R.sup.2 can be combined together directly or through a hetero atom); m is 0 or 1; and the broken line shows the presence of a double bond at position 2 or 3, preparable from the compounds shown by the above formula in which Z is an oxygen by treatment with a compound shown by the formula H.sub.2 Z; and pharmaceuticals containing these compounds.
    以下的化学式代表抗菌头孢菌素:其中A和B分别是氢原子或氨基保护基团;X是羟基或羧基保护基团;Y是氢原子、卤素、烷基、烷氧基或烷硫基;R是氢原子或烷基;Z是下列式的基团(其中R.sup.1和R.sup.2相同或不同,是氢原子、可选择取代的碳氢基团、有机酰基,或下列式的基团(其中M和M'相同或不同,是氧原子或硫原子;R.sup.3是碳氢基团;R.sup.1和R.sup.2可以直接结合或通过杂原子连接);m是0或1;虚线表示位置2或3处有双键存在,可以通过上述式中Z为氧原子的化合物与式为H.sub.2 Z的化合物处理制备;以及含有这些化合物的药物。
  • [EN] HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE TRANSPORT NUCLÉAIRE CONTENANT DE L'HYDRAZIDE ET LEURS UTILISATIONS
    申请人:KARYOPHARM THERAPEUTICS INC
    公开号:WO2013019548A1
    公开(公告)日:2013-02-07
    The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    这项发明通常与核运输调节剂有关,例如CRM1抑制剂,更具体地涉及一种由结构式(I)表示的化合物,或其药学上可接受的盐,其中变量的值和备选值如本文所定义和描述。该发明还包括合成和使用结构式I的化合物,或其药学上可接受的盐或组合物,例如在与CRM1活性相关的生理状况的治疗、调节和/或预防中的应用。
  • [EN] USE OF DYNAMIC MIXTURES FOR A CONTROLLED RELEASE OF FRAGRANCES<br/>[FR] UTILISATION DE MELANGES DYNAMIQUES POUR LIBERATION CONTROLEE DE FRAGRANCES
    申请人:FIRMENICH & CIE
    公开号:WO2006016248A1
    公开(公告)日:2006-02-16
    The present invention relates to a delivery system in the form of a dynamic mixture obtained by reacting together, in the presence of water, at least one hydrazine derivative with at least one perfuming, flavoring, insect repellent or attractant, bactericide and/or fungicide aldehyde or ketone. The invention's mixture is capable of releasing in a controlled and prolonged manner said aldehyde or ketone in the surrounding environment. Furthermore, the present invention concerns also the use of said dynamic mixtures as perfuming ingredients as well as the perfuming compositions or perfumed articles comprising the invention's mixtures.
    本发明涉及一种交互反应得到的动态混合物形式的递送系统,所述动态混合物是通过在水的存在下,将至少一种肼衍生物与至少一种香料、调味剂、驱虫剂或诱引剂、杀菌剂和/或杀菌醛或酮一起反应而获得的。本发明的混合物能够在周围环境中以受控和持久的方式释放所述的醛或酮。此外,本发明还涉及将所述动态混合物用作香料成分,以及包含本发明混合物的香水组合物或香水制品的用途。
  • Controlled Release of Volatile Aldehydes and Ketones from Dynamic Mixtures Generated by Reversible Hydrazone Formation
    作者:Barbara Levrand、Wolfgang Fieber、Jean-Marie Lehn、Andreas Herrmann
    DOI:10.1002/hlca.200790237
    日期:2007.12
    Delivery systems generated by reversible hydrazone formation from hydrazine derivatives (see Fig. 1) and carbonyl compounds in H2O efficiently increase the long-lastingness of volatile aldehydes and ketones (R1R2CO) in various perfumery applications. The hydrazones are usually obtained in an (E) configuration at the imine double bond (NHNC) and, in the case of aliphatic acylhydrazones R′CONHNCR1R2
    在H 2 O中由肼衍生物(见图1)和羰基化合物可逆形成而生成的传递系统有效地提高了各种香料应用中挥发性醛和酮(R 1 R 2 CO)的持久性。通常以(E)构型在亚胺双键(NHNC)上获得,对于脂族酰基hydr R'CONHNCR 1 R 2(R'=烷基),相对于酰胺而言,其为顺式和反式构象异构体键(CONHN)。平均自由能垒约为。通过可变温度的1 H-NMR测量确定了78 kJ / mol的酰胺键旋转(图2)。在H 2 O存在下,的形成是完全可逆的,达到了由肼衍生物,羰基化合物和相应的composed组成的平衡。通过UV / VIS光谱进行的动力学测量表明,that的形成和水解达到了相同的平衡。速率常数强烈依赖于pH值,并且随着pH值的降低而增加(表1)。肼结构对速率常数的影响不如pH效应那么明显,表面活性剂的存在降低了平衡速率(表1和表2)。3)。formation形成的完全可逆性允许通
  • Molybdenum-Mediated One-Pot Synthesis of Pyrazoles from Isoxazoles
    作者:Marine Rey、Stéphane Beaumont
    DOI:10.1055/s-0039-1690615
    日期:2019.10
    with nonsymmetric isoxazoles. By using readily available starting materials, a wide range of substituted pyrazoles may be synthesized by this method. A one-pot approach for the direct synthesis of substituted pyrazoles from isoxazoles is reported. The process involves isoxazole N–O bond cleavage mediated by a molybdenum complex, in situ hydrolysis of the resulting β-amino enone to the corresponding 1,3-diketone
    抽象的 报道了一种从异恶唑直接合成取代的吡唑的一锅法。该过程涉及由钼络合物介导的异恶唑N–O键断裂,将所得的β-氨基烯酮原位水解为相应的1,3-二酮,然后在肼或取代的肼存在下形成吡唑。用非对称异恶唑可获得良好或优异的产率和区域选择性。通过使用容易获得的起始原料,可以通过该方法合成各种各样的取代的吡唑。 报道了一种从异恶唑直接合成取代的吡唑的一锅法。该过程涉及由钼络合物介导的异恶唑N–O键断裂,将所得的β-氨基烯酮原位水解为相应的1,3-二酮,然后在肼或取代的肼存在下形成吡唑。用非对称异恶唑可获得良好或优异的产率和区域选择性。通过使用容易获得的起始原料,可以通过该方法合成各种各样的取代的吡唑。
查看更多

同类化合物

苯甲酸,4-(1,3-二噁烷-2-基)- 甲基四氢-2-噻吩羧酸酯 环丁砜 烯丙基-(3-甲基-1,1-二氧代-四氢-1lambda*6*-噻吩-3-基)-胺 氯(四氢噻吩)金(I) 四甲基亚砜 四氢噻吩二醇 四氢噻吩-3-酮 四氢噻吩-3-羧酸-1,1-二氧 四氢噻吩-2,5-二酮 四氢噻吩-1,1-二亚基二胺 四氢噻吩 四氢-噻吩-3-醇 四氢-N-甲基-N-亚硝基-3-噻吩胺1,1-二氧化物 四氢-3-噻吩羧酸甲酯 四氢-3-噻吩羧酸 四氢-3-噻吩磺酰氯 1,1-二氧化物 四氢-3-噻吩硫醇1,1-二氧化物 四氢-3-噻吩甲酰氯1,1-二氧化物 四氢-3-噻吩甲腈1,1-二氧化物 四氢-3-噻吩基甲基丙烯酸酯 四氢-3,4-噻吩二胺1,1-二氧化物 四氢-2-噻吩羧酸 四亚甲基-D8砜 噻吩,四氢-2,2,5,5-四甲基- 八氟四氢噻吩 1,1-二氧化物 全氟四氢噻吩 二甲基砜茂烷 二氢-5,5-二甲基噻吩-3(2H)-酮 二氢-2-甲基-3(2H)-噻吩酮 乙基四氢-3-噻吩羧酸酯 Γ--硫代丁内酯 beta-乙基-beta-甲基-硫代丁内酯 alpha-乙基,alpha-甲基-硫代丁内酯 [[[(四氢噻吩1,1-二氧化物)-3-基]亚氨基]二(亚甲基)]二膦酸 [(1,1-二氧代四氢-3-噻吩基)甲基]胺 [(1,1-二氧代-3-四氢噻吩基)氨基]二硫代甲酸钾盐 N-烯丙基四氢-3-噻吩胺1,1-二氧化物 N-丁基-N-(1,1-二氧代四氢噻吩-3-基)胺盐酸盐 N-(1,1-二氧代四氢噻吩-3-基)乙酰胺 N'-(1,1-二氧代-四氢噻吩-3-基)-N,N-二甲基-乙烷-1,2-二胺 7-硫杂双环[2.2.1]庚-5-烯-2-羧酸 5-氧代四氢-2-噻吩羧酸 5-氧代-四氢噻吩-3-羧酸甲酯 5-[(1R,2S,5S)-7-氧代-3-硫杂-6,8-二氮杂双环[3.3.0]辛-2-基]戊酰胺 4a,8alpha-(甲桥硫代甲桥)萘10,10-二氧化物 4-肼基四氢噻吩-3-醇1,1-二氧化物 4-甲基氨基-1,1-二氧代-四氢-1lambda*6*-噻吩-3-醇 4-甲基-3-氧代四氢噻吩 4-溴二氢噻吩-3(2H)-酮 1,1-二氧化物